|
|
Expression and Clinical Significance of Histone Deacetylase (HDAC9) in Nasopharyngeal Carcinoma |
LI An, ZHU Xu-li, ZHAO Yu-xiang,et al |
Shaanxi Provincial People's Hospital,Xi'an Shaanxi 710068 |
|
|
Abstract 【Objective】To explore the expression of histone deacetylase 9 (HDAC9) in nasopharyngeal carcinoma and its clinical significance. 【Methods】A total of 41 patients with nasopharyngeal carcinoma confirmed by pathological biopsy in Otorhinolaryngology of our hospital were selected as the observation group. In addition,24 patients with chronic nasopharyngitis were selected as the control group. The expression of HDAC9 protein was detected by immunohistochemistry; the relative expression of HDAC9 mRNA was detected by real-time fluorescent quantitative PCR (qRT-PCR). The three-year survival of nasopharyngeal carcinoma patients in the HDAC9 mRNA high expression group and the HDAC9 mRNA low expression group were compared and analyzed. 【Results】Immunohistochemistry showed that the expression of HDAC9 protein in the observation group was significantly lower than that in the control group (P<0.05); qRT-PCR showed that the relative expression of HDAC9 mRNA in the observation group was significantly lower than that in the control group (P<0.05). The number of cases with high expression of HDAC9 mRNA (n=30) was much higher than that of cases with low expression (n=11) in nasopharyngeal carcinoma tissues (P<0.05).The expression of HDAC9 mRNA was not related to gender,age and pathological type (P>0.05),while its expression was related to lymph node metastasis and TNM stage (P<0.05). The 3-year survival rate of patients with high expression of HDAC9 mRNA was 56.67% (17/30) and the 3-year survival rate with low expression was 81.82% (9/11). The survival rate of HDAC9 mRNA high expression group was lower than that of low expression group (P>0.05). 【Conclusion】The expression of HDAC9 is low in nasopharyngeal carcinoma patients,and the expression of HDAC9 mRNA is related to lymph node metastasis and TNM stage.
|
Received: 06 December 2021
|
|
|
|
|
[1] MILAZZO G,MERCATELLI D,DI MUZIO G,et al. Histone deacetylases (HDACs):evolution,specificity,role in transcriptional complexes,and pharmacological actionability[J].Genes (Basel),2020,11(5):1-49.
[2] 赵玉鑫.HDAC9在骨肉瘤中表达和功能的实验研究[D].河南:郑州大学,2017.
[3] 付洋,孔垂泽.组蛋白去乙酰化酶9在肿瘤中的作用[J].中国肿瘤临床,2018,45(24):50-54.
[4] 杨洪斌. 人防御素HNP-1基因转染对祼鼠鼻咽癌移植瘤生长影响的实验研究[D].四川:四川大学,2007.
[5] 孙懿. 应用RNA干扰和蛋白质组学技术研究鼻咽癌细胞中p53的功能[D].湖南:中南大学,2007.
[6] 许琨. 新型溶肿瘤腺病毒Ad-TD-RFP对人鼻咽癌的治疗作用[D].河南:郑州大学,2012.
[7] LINO CARDENAS C L,KESSINGER C W,CHENG Y,et al.An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm[J].Nat Commun,2018,9(1):1009.
[8] SUN Y, YUE S,WANG Y. Histone Deacetylase Inhibitors in Cancer Therapy[J].Cur Top Med Chem,2018,18(28):2420-2428.
[9] YAN M,QIAN YM,YUE CF,et al. Inhibition of histone deacetylases induces formation of multipolar spindles and subsequent p53-dependent apoptosis in nasopharyngeal carcinoma cells[J].Oncotarget,2016,7(28):44171-44184.
[10] SHEN Z,LIAO X,SHAO Z,et al. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability[J].BMC Cancer,2019,19(1):262.
[11] RASTOGI B,RAUT SK,PANDA NK ,et al.Over expression of HDAC9 promotes oral squamous cell carcinoma growth,regulates cell cycle progression,and inhibits apoptosis[J].Mol Cell Biochem,2016,415(1-2):183-196.
[12] RASTOGI B,KUMAR A,RAUT SK,et al. Down regulation of miR-377 Promotes oral squamous cell carcinoma growth and migration by targeting HDAC9[J].Cancer Invest,2017,35(3):1-11. |
|
|
|